Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 29, 2017

DrugPatentWatch Database Preview

Fosinopril sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for fosinopril sodium and what is the scope of patent protection?

Fosinopril sodium
is the generic ingredient in four branded drugs marketed by Apotex Inc, Bristol Myers Squibb, Actavis Labs Fl Inc, Invagen Pharms, Watson Labs, Teva, Aurobindo Pharma Ltd, Prinston Inc, Ranbaxy Labs Ltd, Upsher-smith Labs, Mylan, Emcure Pharms India, Sun Pharm Inds Ltd, Aurobindo Pharma, and Sandoz, and is included in twenty-two NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for fosinopril sodium. Seventeen suppliers are listed for this compound.

Summary for Generic Name: fosinopril sodium

Drug Master File Entries: see list6
Suppliers / Packagers: see list17
Bulk Api Vendors: see list57
Clinical Trials: see list924
Patent Applications: see list1,311
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:fosinopril sodium at DailyMed

Pharmacology for Ingredient: fosinopril sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc
fosinopril sodium
TABLET;ORAL076906-003May 17, 2005ABRXNoNo► Subscribe► Subscribe
Bristol Myers Squibb
fosinopril sodium
TABLET;ORAL019915-003May 16, 1991DISCNYesNo► Subscribe► Subscribe
Aurobindo Pharma
fosinopril sodium; hydrochlorothiazide
TABLET;ORAL079245-002Jul 9, 2009ABRXNoNo► Subscribe► Subscribe
Watson Labs
fosinopril sodium
TABLET;ORAL077531-003Aug 31, 2006DISCNNoNo► Subscribe► Subscribe
Watson Labs
fosinopril sodium; hydrochlorothiazide
TABLET;ORAL077144-002Aug 16, 2005DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus